| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
2 companies
Ronald Harold Wilfred Cooper is Chief Executive Officer at ENGN, with reported holdings spanning 2 companies. Ronald Harold Wilfred Cooper's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $65K at current prices.
Ronald Harold Wilfred Cooper's largest disclosed position is in GBIO as Director, worth about $49K.
Ronald Harold Wilfred Cooper has 13 Form 4 filings on record from March 2021 to June 2026, across 3 companies: Director at C4 Therapeutics (CCCC), 2024–2026; CEO & President at enGene (ENGN), 2024–2026; Director at Generation Bio (GBIO), 2021–2025.
The 13 reported transactions were 11 option or other derivative awards, 1 open-market purchase and 1 stock award.
Counted by filing, the open-market trades come to 1 purchase worth about $57K and no sales.
The only open-market purchase was 10,000 shares of ENGN at an average $5.70 on September 27, 2024, about $57K. Twelve months later ENGN was up 7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | ENGN Engene Holdings Inc. | Chief Executive Officer | Buy | 10,000 | $5.70 | $57,000.00 | New | +1.5% | +7.3% |